FI53457C - FOERFARANDE FOER FRAMSTAELLNING AV SAODANA 2-ARYL- 2-CYCLOALKYL- OCH 2-ALKYL-8-AZAPURIN-6-ONDERIVAT SOM LAEMPAR SIG FOER VAORD AV ANDNINGSSJUKDOMAR - Google Patents

FOERFARANDE FOER FRAMSTAELLNING AV SAODANA 2-ARYL- 2-CYCLOALKYL- OCH 2-ALKYL-8-AZAPURIN-6-ONDERIVAT SOM LAEMPAR SIG FOER VAORD AV ANDNINGSSJUKDOMAR

Info

Publication number
FI53457C
FI53457C FI3560/71A FI356071A FI53457C FI 53457 C FI53457 C FI 53457C FI 3560/71 A FI3560/71 A FI 3560/71A FI 356071 A FI356071 A FI 356071A FI 53457 C FI53457 C FI 53457C
Authority
FI
Finland
Prior art keywords
foer
vaord
onderivat
andningssjukdomar
saodana
Prior art date
Application number
FI3560/71A
Other languages
Finnish (fi)
Other versions
FI53457B (en
Inventor
Barbara Joyce Broughton
Bryan John Large
Stuart Malcolm Marshall
David Lord Pain
Kenneth Robert Harr Wooldridge
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Application granted granted Critical
Publication of FI53457B publication Critical patent/FI53457B/fi
Publication of FI53457C publication Critical patent/FI53457C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI3560/71A 1970-12-15 1971-12-14 FOERFARANDE FOER FRAMSTAELLNING AV SAODANA 2-ARYL- 2-CYCLOALKYL- OCH 2-ALKYL-8-AZAPURIN-6-ONDERIVAT SOM LAEMPAR SIG FOER VAORD AV ANDNINGSSJUKDOMAR FI53457C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB5955270 1970-12-15
GB5955670 1970-12-15
GB4975671A GB1338235A (en) 1970-12-15 1971-10-26 Azapurinones
GB5345771 1971-11-17

Publications (2)

Publication Number Publication Date
FI53457B FI53457B (en) 1978-01-31
FI53457C true FI53457C (en) 1978-05-10

Family

ID=27449009

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3560/71A FI53457C (en) 1970-12-15 1971-12-14 FOERFARANDE FOER FRAMSTAELLNING AV SAODANA 2-ARYL- 2-CYCLOALKYL- OCH 2-ALKYL-8-AZAPURIN-6-ONDERIVAT SOM LAEMPAR SIG FOER VAORD AV ANDNINGSSJUKDOMAR

Country Status (25)

Country Link
US (1) US3987160A (en)
JP (1) JPS5310599B1 (en)
AR (4) AR192602A1 (en)
AT (4) AT317211B (en)
AU (1) AU458277B2 (en)
BE (1) BE776683A (en)
BG (3) BG20807A3 (en)
CH (5) CH555351A (en)
DD (1) DD95007A5 (en)
DE (1) DE2162096A1 (en)
DK (1) DK141249B (en)
FI (1) FI53457C (en)
FR (1) FR2118078B1 (en)
GB (1) GB1338235A (en)
HK (1) HK42177A (en)
HU (1) HU165079B (en)
IE (1) IE35897B1 (en)
IL (1) IL38364A (en)
IS (1) IS1099B6 (en)
LU (1) LU64457A1 (en)
NL (1) NL174943C (en)
NO (1) NO134257C (en)
OA (1) OA03930A (en)
SE (1) SE393381B (en)
ZM (1) ZM18971A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1493685A (en) * 1970-12-15 1977-11-30 May & Baker Ltd 8-azapurinones
BE792648A (en) * 1971-12-13 1973-06-12 May & Baker Ltd ISOQUINOLEINE DERIVATIVES
FR2406638A1 (en) * 1977-10-21 1979-05-18 May & Baker Ltd 2-Alkoxy-phenyl-8-aza-purinone derivs. - useful for treating respiratory disorders, such as allergic asthma
EP0007727B1 (en) * 1978-07-24 1983-11-30 Beecham Group Plc Benzopyranotriazoles, preparation of these compounds and pharmaceutical composition containing them
JPS60226887A (en) * 1984-04-25 1985-11-12 Dai Ichi Seiyaku Co Ltd Triazolopyrimidine derivative
CA1303037C (en) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
US5204353A (en) * 1987-04-07 1993-04-20 Ciba-Geigy Corporation 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith
DE3873812D1 (en) * 1987-04-07 1992-09-24 Ciba Geigy Ag 3H-1,2,3-TRIAZOLO (4,5-D) PYRIMIDINE.
FR2618073B1 (en) * 1987-07-16 1990-09-07 Pf Medicament HYDROPHILIC MATRIX-TYPE TABLETS BASED ON SALBUTAMOL AND THEIR PREPARATION METHOD
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
DE4211239C2 (en) * 1992-04-03 1995-11-16 Max Planck Gesellschaft Medicines for cardiovascular diseases
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US20080045573A1 (en) * 1993-09-20 2008-02-21 Bova David J Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
SI1049695T1 (en) 1997-11-12 2002-06-30 Bayer Aktiengesellschaft 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DE19838705A1 (en) 1998-08-26 2000-03-02 Bayer Ag New dihydro- (1,2,3) -triazolo- [4,5-d] pyrimidin-7-ones
IT1318674B1 (en) * 2000-08-08 2003-08-27 Nicox Sa DO IT FOR INCONTINENCE.
DE10232113A1 (en) 2002-07-16 2004-01-29 Bayer Ag Medicinal products containing vardenafil hydrochloride trihydrate
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102005009240A1 (en) 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with improved pharmacokinetic properties
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (en) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2012223337C1 (en) 2011-03-01 2016-11-10 Bausch Health Ireland Limited Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
CN105764916B (en) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 Ultrapure agonists of guanylate cyclase C, methods of making and using the same
MX375926B (en) 2013-08-09 2025-03-07 Ardelyx Inc COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT.
CN110381951A (en) 2016-12-14 2019-10-25 瑞必治公司 For treating the method and composition of pulmonary hypertension He other lung disorders
TWI845600B (en) * 2019-01-24 2024-06-21 美商普羅米修斯生物科學股份有限公司 Gpr35 modulators
JP2022533251A (en) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド Combinations to lower serum phosphate in patients
CA3186635A1 (en) * 2020-07-23 2022-01-27 Robert Higuchi Therapeutic agents targeting gpr35

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407204A (en) * 1944-07-22 1946-09-03 American Cyanamid Co Triazolo (d) pyrimidines and methods of preparing the same
US2993039A (en) * 1959-11-06 1961-07-18 Upjohn Co Preparing nu-glycosides of aldose and ketose sugars

Also Published As

Publication number Publication date
LU64457A1 (en) 1972-08-23
DK141249C (en) 1980-08-04
JPS5310599B1 (en) 1978-04-14
AR199468A1 (en) 1974-09-09
IE35897L (en) 1972-06-15
AU458277B2 (en) 1975-02-20
DK141249B (en) 1980-02-11
IL38364A0 (en) 1972-02-29
AT317211B (en) 1974-08-26
IS1099B6 (en) 1982-11-18
AU3686771A (en) 1973-06-21
AR192602A1 (en) 1973-02-28
DE2162096A1 (en) 1972-07-06
BG20806A3 (en) 1975-12-20
FR2118078B1 (en) 1975-08-01
CH556860A (en) 1974-12-13
BE776683A (en) 1972-06-14
ZM18971A1 (en) 1972-08-21
BG20807A3 (en) 1975-12-20
CH546779A (en) 1974-03-15
FI53457B (en) 1978-01-31
AR192689A1 (en) 1973-02-28
DD95007A5 (en) 1973-01-12
GB1338235A (en) 1973-11-21
CH552610A (en) 1974-08-15
OA03930A (en) 1975-08-14
AT319235B (en) 1974-12-10
CH555351A (en) 1974-10-31
NL174943C (en) 1984-09-03
NL7117142A (en) 1972-06-19
NO134257B (en) 1976-05-31
IE35897B1 (en) 1976-06-23
IL38364A (en) 1975-08-31
AR199467A1 (en) 1974-09-09
NO134257C (en) 1976-09-08
AT315838B (en) 1974-06-10
NL174943B (en) 1984-04-02
DE2162096C2 (en) 1988-02-11
US3987160A (en) 1976-10-19
IS2047A7 (en) 1972-06-16
CH550814A (en) 1974-06-28
HK42177A (en) 1977-08-19
HU165079B (en) 1974-06-28
FR2118078A1 (en) 1972-07-28
BG20805A3 (en) 1975-12-20
SE393381B (en) 1977-05-09
AT315839B (en) 1974-06-10

Similar Documents

Publication Publication Date Title
FI53457C (en) FOERFARANDE FOER FRAMSTAELLNING AV SAODANA 2-ARYL- 2-CYCLOALKYL- OCH 2-ALKYL-8-AZAPURIN-6-ONDERIVAT SOM LAEMPAR SIG FOER VAORD AV ANDNINGSSJUKDOMAR
FI54057B (en) FOERFARANDE FOER FRAMSTAELLNING AV EN SKUMDAEMPARKOMPOSITION
FI54032C (en) NORMERINGSFOERFARANDE FOER MAETNINGSANORDNING FOER BESTAEMNING AV KVADRAT METERVIKT
FI54345C (en) FOERFARANDE FOER FRAMSTAELLNING AV CELLULOSAMASSA
FI54854B (en) FOERFARANDE FOER FRAMSTAELLNING AV EN ROEKPRODUKT
FI54139C (en) FOERFARANDE FOER KATALYTISK KRACKNING AV BENSIN
FI53903B (en) KOPPLINGSPLINT FOER SKRUVFRI ANSLUTNING AV ISOLERADE LEDARE
FI54586C (en) FOERFARANDE FOER AVLAEGSNANDE AV KVICKSILVERCELL FRAON EN KLORHALTIG AVFALLSSALTLOESNING FRAON EN KVICKSILVERCELL
FI53297C (en) FUERFARANDE ATT UPPARBETA AVFALLSVATTEN SOM INNEHAOLLER KVICKSILVERFOERORENINGAR
FI53839C (en) FOERFARANDE FOER KALKNING AV DJURSKINN ELLER -HUDAR
FI54550B (en) FOERFARANDE FOER FRAMSTAELLNING AV MARGARINFETT
FI53825B (en) FRAMSTAELLNING AV ETYLENPROPYLENKOPOLYMER MED TRIFENYLPOSFIT SOM KATALYSATORHJAELPMEDEL
FI54482C (en) FOERFARANDE FOER FRAMSTAELLNING AV BRONKOLYTISKT AKTIVA TEOFYLLINDERIVAT
FI53521C (en) ROEKDETEKTOR FOER OPTISK DETEKTERING AV FOERBRAENNINGSALSTRADE AEROSOLER
FI54350B (en) FOERFARANDE FOER OXIDERING AV SVARTLUT
FI54405C (en) ANLAEGGNING FOER KYLNING AV AONGA
FI54246B (en) ANORDING FOER ATT BILDA EN FOERETRAEDESVIS KEMISKT REAKTIONSBENAEGEN BLANDNING AV KONSTAEMNESKONPONENTER
FI53842B (en) FOERFARANDE FOER FRAMSTAELLNING AV FIBERPRODUKTER
FI53450C (en) FOERFARANDE FOER FRAMSTAELLNING AV OPTISKT AKTIVA BICYKLISKA FOERENINGAR
FI53304C (en) FOERFARANDE FOER FRAMSTAELLNING AV DES-FENYLALANIN B1-INSULIN
FI54219B (en) ANVAENDNING AV SUBSTITUERADE FENYLTIOKARBAMATER FOER SELEKTIV BEKAEMPNING AV OGRAES
FI54303B (en) NYTT FOERFARANDE FOER FRAMSTAELLNING AV METYL-1-NAFTYLDITIOCARBAMINSYRA-2-BENZOXAZOLYLESTER
FI54321B (en) FOERFARANDE FOER FRAMSTAELLNING AV FOERBAETTRADE VAEDERBESTAENDIG TITANDIOXIDPIGMENT
FI46554B (en) UTNYTTJANDE AV FOERBRAENNINGSMOTORS AVGASFILTER SOM VAERMEAPPARAT
FI55397C (en) SPAENNBULT, SAERSKILT FOER UPPBAERANDE AV RADIATORER